Home/Filings/4/0001562180-22-001085
4//SEC Filing

Consylman Gina 4

Accession 0001562180-22-001085

CIK 0001293971other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:07 PM ET

Size

10.9 KB

Accession

0001562180-22-001085

Insider Transaction Report

Form 4
Period: 2022-02-01
Consylman Gina
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-02-01+25,000125,385 total
  • Award

    Stock Option (right to buy)

    2022-02-01+50,00050,000 total
    Exercise: $7.80Exp: 2032-02-01Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2023, 25% on 01/04/2024, 25% on 01/04/2025, and 25% on 01/04/2026.
  • [F2]This stock option vests over a four-year period at the rate of 25% on 01/04/2023 and then in 36 equal monthly installments thereafter.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001546358

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:07 PM ET
Size
10.9 KB